Brit. med.J., 1968, 2, [213] [214] When digitalis fails to control atrial fibrillation propranolol may be useful in slowing the ventricular rate (Besterman and Friedlander, 1965 ; Rowlands et al., 1965) . The beta-adrenergic blockade which propranolol causes may induce or aggravate cardiac failure, as cardiac sympathetic nervous stimulation is an important factor supporting myocardial function (Gaffney and Braunwald, 1963) . Therefore it is likely that in some patients propranolol may control the heart rate at the expense of myocardial efficiency. This paper reports the cases of four patients with atrial fibrillation and chronic valvar heart disease in whom propranolol was used to control the ventricular rate when digitalis had failed. In each case, though the rate was adequately controlled, heart failure occurred. On admission the pulse rate was 50/min. The jugular venous pressure was raised. A chest radiograph showed that the cardiothoracic ratio had increased from 56 to 64% over the six-week period during which propranolol had been given. Pulmonary venous congestion had appeared.
Propranolol was withdrawn, digoxin was continued, and diuretics were started. Over the next three days the heart rate rose to 120/ min. An increase in the dose of digoxin resulted in-satisfactory control of the ventricular rate. One week after admission the chest radiograph showed the cardiothoracic ratio had decreased to 51%; pulmonary venous congestion had cleared.
Discussion
The risk of inducing cardiac failure with propranolol is now well established and most reviews allude to it. At the symposium on beta-adrenergic receptor blockade at Buxton, Stephen (1966) reviewed the published experience in 1,500 patients receiving propranolol orally for various reasons. He noted 13 in whom cardiac failure was recorded as a complication. Three of these cases had rheumatic heart disease. At the same symposium the action of propranolol in slowing rapid atrial fibrillation was underlined (Szekely et al., 1966) .
In the four cases reported above the patients had chronic valvar diseae with atrial fibrillation and in each case control of the ventricular rate had proved difficult with digitalis. Recourse to propranolol was certainly highly effective in slowing the heart; this was strikingly illustrated by the first patient, whose rate was only 90/min. in the presence of gross left ventricular failure. In each instance the slow pulse appears to have induced a false sense of security, particularly in Cases 2 and 3, where digitalis and diuretics were also being given. In these circumstances deterioration in a patient's condition might well be ascribed to the inevitable progress of heart disease unless the possible adverse action of propranolol on myocardial function were kept in mind. Certainly, each patient had important valvar disease, which imposes a progressive burden on the myocardium, but in view of the sequence of events and the accepted pharmacological action of propranolol it seems likely that this drug precipitated cardiac failure.
Many patients with rapid atrial fibrillation, apparently refractory to digitalis, are underdigitalized. Occasionally they do not take the digitalis prescribed, or they fail to absorb it; sometimes they need unusually large amounts. If these patients are given propranolol the reduction in heart rate masks the need for digitalis. Indeed we have noticed that patients taking propranolol sometimes have such slow heart rates that digitalis is temporarily withheld for fear of overdosage. Digitalis is reputed to protect the heart to some degree from propranolol.-induced failure, since its positive inotropic action is not influenced by beta blockade (Levy and Richards, 1965) . Patients who are underdigitalized are therefore more vulnerable to this danger. Three patients (Cases 2, 3, and 4) were probably inadequately digitalized judging by the sharp rise in heart rate when propranolol was stopped. In Case 2 this tachycardia occurred despite increased digitalis dosage. Later, rate control was established with digitalis alone.
Even if adequate digitalis is given, propranolol should be employed with particular care if used to control rapid atrial fibrillation in patients with chronic valvar disease. In uncomplicated mitral stenosis, where diastolic filling time is at a premium, the reduction in ventricular rate produced by beta blockade may be helpful (Stock, 1966) . With most other severe valve lesions the use of propranolol is more hazardous because of impaired myocardial function. The manufacturers are at pains to point out the risk of inducing heart failure with propranolol, but judging from our experience this hazard needs emphasizing.
Summary
The cases of four patients with important chronic rheumatic valvar disease are described, in whom atrial fibrillation was difficult to control with digitalis. Propranolol was successfully used to slow the ventricular rate, but, though two of the patients were on diuretics, heart failure resulted. Three patients were probably inadequately digitalized. The role of propranolol in causing or accelerating heart failure is discussed, and it is concluded that the use of this drug for controlling atrial fibrillation in the presence of significant valvar disease is hazardous.
